<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04923828</url>
  </required_header>
  <id_info>
    <org_study_id>fdpicu-21</org_study_id>
    <nct_id>NCT04923828</nct_id>
  </id_info>
  <brief_title>Chinese PICU Collaborative Network on Pathogens and Drug Resistance of Severe Infections</brief_title>
  <official_title>Children's Hospital of Fudan University</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Guoping Lu</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Shanghai Children's Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Shanghai Children's Medical Center</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Ningbo Women &amp; Children's Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Anhui Provincial Children's Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Xian Children's Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>The Children's Hospital of Zhejiang University School of Medicine</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Qilu Children's Hospital of Shandong University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Children's Hospital of Fudan University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      To investigate PICUs in major cities in China by establishing a high-quality standardized&#xD;
      clinical database of PICU inpatients Incidence, fatality rate, pathogen distribution,&#xD;
      anti-infective treatment of community-acquired/nosocomial infections in inpatients.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      All patients admitted to the PICU during January 1, 2016 to December 31 2025 were included in&#xD;
      the study, and all patients were followed up until death or PICU withdrawal. To establish the&#xD;
      standardized Access database collected patients' general information, infection, PICU&#xD;
      treatment, catheter, and short-term Prognosis and other clinical data.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">December 1, 2021</start_date>
  <completion_date type="Anticipated">December 31, 2026</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2025</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <target_duration>1 Year</target_duration>
  <primary_outcome>
    <measure>Pathogenic spectrum of PICU severe infection</measure>
    <time_frame>2016-2025</time_frame>
    <description>the 10 years of pathogenic spectrum of PICU severe infection</description>
  </primary_outcome>
  <enrollment type="Anticipated">2000</enrollment>
  <condition>Severe Infection</condition>
  <eligibility>
    <study_pop>
      <textblock>
        PICU patients with severe infection&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  PICU patients with severe infection&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Non-infected patient&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>1 Month</minimum_age>
    <maximum_age>16 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Guoping Lu, Doctor</last_name>
    <role>Principal Investigator</role>
    <affiliation>Children's Hospital of Fudan University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Guoping Lu, Doctor</last_name>
    <phone>13788904150</phone>
    <email>13788904150@163.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Jing Liu, Master</last_name>
    <phone>15800523953</phone>
    <email>liujinggg@126.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Children's Hospital of Fudan University</name>
      <address>
        <city>Shanghai</city>
        <state>Shanghai</state>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>June 7, 2021</study_first_submitted>
  <study_first_submitted_qc>June 8, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">June 11, 2021</study_first_posted>
  <last_update_submitted>October 20, 2021</last_update_submitted>
  <last_update_submitted_qc>October 20, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 21, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Children's Hospital of Fudan University</investigator_affiliation>
    <investigator_full_name>Guoping Lu</investigator_full_name>
    <investigator_title>Chief of PICU</investigator_title>
  </responsible_party>
  <keyword>PICU</keyword>
  <keyword>pathogen</keyword>
  <keyword>severs infection</keyword>
  <keyword>drug resistance</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infections</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

